In addition to the loss of normal p53 function through deletion or intragenic mutation, a class of ‘gain-of-function’ mutants exists2, in which the encoded proteins are endowed with oncogenic properties that actively drive tumour progression3. This evidence concerns the gene TP53 and neoplasm.